Leveraging the Holistic Benefits of Biosimilars in Europe - Part 2: How Payers Can Safeguard the Future of a Healthy Biosimilar Market Environment
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH(2024)
关键词
Biosimilar,Europe,health technology assessment,market access,payer,value
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要